(Q45134478)

English

The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression

scientific article published in January 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

author name string

Szegedi A

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Rujescu D

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Tadic A

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Müller MJ

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Kohnen R

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Stassen HH

6

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Dahmen N

7

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

The Pharmacogenomics Journal

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

49-53

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Tryptophan hydroxylase gene associated with paroxetine antidepressant activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

21 January 2018

Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

21 January 2018

Moclobemide response in depressed patients: association study with a functional polymorphism in the monoamine oxidase A promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

21 January 2018

Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

21 January 2018

SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

21 January 2018

A Review of the Pharmacological and Clinical Profile of Mirtazapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

21 January 2018

Presynaptic adrenergic receptor sensitivity in depression. The effect of long-term desipramine treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

21 January 2018

Locus coeruleus neuronal activity and noradrenaline availability in the frontal cortex of rats chronically treated with imipramine: effect of alpha 2-adrenoceptor blockade.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

21 January 2018

Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

21 January 2018

The Relationship between COMT Genotype and the Clinical Effectiveness of Tolcapone, a COMT Inhibitor, in Patients with Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

21 January 2018

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

7 January 2021

based on heuristic

inferred from DOI database lookup

Serotonin transporter gene polymorphism and antidepressant response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

7 January 2021

based on heuristic

inferred from DOI database lookup

Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

7 January 2021

based on heuristic

inferred from DOI database lookup

Genotypes of catechol-O-methyltransferase and response to levodopa treatment in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

7 January 2021

based on heuristic

inferred from DOI database lookup

Mirtazapine compared with paroxetine in major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500289

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.TPJ.6500289

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45134478&oldid=2207112983"